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Summary: Jejunal perfusion in the rat with Ringer solution containing 10 mmol/1 taurocholate removes con-
siderable quantities of protein and brush border membrane enzymes from the intestinal epithelium. The
duration of the experiments was 7.5 h. One group of animals was given 200 g cycloheximide per 100 g body
weight intramuscularly l h before Start of the perfusion. Serial estimations of protein and of four brush border
membrane enzymes (alanine aminopeptidase, alkaline phosphatase, -glutamyl transferase, and enteropepti-
dase) were done in the perfusate. The results provide evidence that during the experiments an increasing
Proportion of the enzymes stems from de novo synthesis. This is consistent with the concept that after loss of
10—30 per cent of erizyme the molecules are replaced by newly synthesized material, provided that the energy
metabolism of the mucosa cells remains intact.
De novo-Synthese von Enzymen der Bürstensaummembran der Ratte während Perfusion des Darms mit Gal-
lensalz
Zusammenfassung: Bei der Ratte werden durch jejunale Perfusion mit Ringer-Lösung, die 10 mmol/1 Tauro-
cholat enthält, beträchtliche Mengen von Eiweiß und Bürstensaumenzymen aus dem Dünndarmepithel ent-
fernt. Die Perfusionsdauer betrug 7,5 h. Eine Gruppe der Tiere erhielt l h vor Beginn der Perfusion 200 g
Cyclpheximid je 100 g Körpergewicht i. m. Im Perfusat wurden Eiweiß und vier Bürstensaumenzyme in Ab-
ständen bestimmt. Die Ergebnisse beweisen, daß während der Versuche ein zunehmender Anteil der Enzyme
aus der Neusynthese stammt. Dies ist mit der Vorstellung vereinbar, daß die Enzymmoleküle nach dem
Verlust von 10—30% durch neusynthetisiertes Material ersetzt werden, vorausgesetzt, daß die Energiesitua-
tioh in den Mucosazellen intakt bleibt.
Introduction
As demonstrated in a previous paper (1) bile salts
are capable of removing considerable quantities of
enzymes from the brush border of the intestinal mu-
cosa of the rat. During a 2.5 h perfusion with Ringer
solution containing 10 mmol/1 taurocholate at least
10 per cent of the original quantity are released from
the plasma membrane. At the same time, the mucosa
epithelium remains intact with respect to both mor-
phology and function. The essential electronmicro-
scopic observation is a rarefication of the apical gly-
cocalyx. Practically no lysosomal or mitochondrial
enzymes are released into the perfusion medium.
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The question arises whether the brush border en-
zyme molecules that appear in the medium are pre-
formed or originale from de novo synthesis. To
answer this question experiments with cyclohexim-
ide, a well-known inhibitor of protein biosynthesis,
were done.
Material and Methods
Female white Wistar rats of about 200 g body weight were used.
After narcosis with Brevinarcon® (ethylbutyl thiobarbital-sodi-
um) 20 cm of the proximal jejunum were cannulated from both
ends and perfused in a cjosed System äs described previously (1).
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The animals were divided into three groups.
(I) perfusion vvith Ringer solution (9.5 g NaCl, 0.5 g KC1, 0.2 g
CaCI2, 0.15 g NaHCO3, 1.0g glucose per liter) (n = 5).
(II) perfusion vvith Ringer solution containing 10 mmol/I sodium
taurocholate (n = 5), and
(III) the samc s (II) after the animals had received 200 μg cyclo-
heximide/lOOg body weight intramuscularly l h before the Start
of the experiment (n = 6).
The duration of the perfusion was proloiiged to 7.5 h. Samples
were taken after 0.25, l, 1.5, 2, 2.5, 3.5, 4.5, 6 and 7.5 h. Protein
and 4 plasma membrane enzymes, viz. alanine aminopeptidase
(EC 3.4.11.2), alkaline phosphatase (EC 3.1.3.1), γ-glutamyl
transferase (EC 2.3.2.2) and enteropeptidase (EC 3.4.21.9) were
estimated according to methods used in our previous work. With
the exception of enteropeptidase the measured enzyme activities
were corrected for the direct influence of bile sah (1).
Results
As can be seen from figures l and 2 the release by
taurocholate pf enzymes and protein is clearly inhi-
bited by cycloheximide. In all cases significant differ-
ences (between p < 0.05 and p < 0.001) are ob-
tained. The moment at which the curves begin to di-
verge seems to vary from l h (enteropeptidase) to
2.5 h (γ-glutamyl transferase) after the Start of the
perfusion. Figure l of course reflects the global ef-













Fig. 1. Cumulative protein concentration in the perfusate s a
function of time.
O—O Ringer solution, D—D 10 mmol/1 taurocholate.
A—Δ the same after administration of cycloheximide.
Vertical brackets at points indicate mean ±1 SEM. n = 5
for Ringer, 5 for taurocholate and 6 for taurocholate +
cycloheximide. **, significant difference between the lat-
ter at the l per cent level.
Discussion
It is evident that during perfusion with bile salt an
increasing proportion of the brush border enzymes
and of released protein stem from de novo synthesis.
A rough estimate leads to the conclusion that de no-
vo synthesis becomes effective when about ΙΟ-θΟ
per cent of the preformed enzymes or protein have
been lost. Enzyme activities and protein content of
normal jejunal mucosa were given in table 2 of our
first communication (1). Urifortunately, there was an
error in our calculation: the values listed in that table
should be divided by 2.2.
These results may be compared with similar investi-
gations on the release of plasma membrane enzymes
from the biliary canaliculi of the liver cells after bile
duct ligation. The increase of alkaline phosphatase in
both liver and serum can be inhibited by agents that
interfere with nucleic acid or protein synthesis, such
s ethionine, cycloheximide, actinomycin and puro-
mycin (2—6). A similar mechanisni could not be
demonstrated for other membrane enzymes, particu-
larly γ-glutamyl transferase (7) and 5'-nucleotidase
(4). On the other hand it seems impossible that in
cases of chronic cholestasis markedly elevated serum
levels of these enzymes (5-15 times normal) should
be maintained for weeks without stimulated synthe-
sis. A time factor may be operative. In our observa-
tions, too, the cycloheximide effect on the release of
γ-glutamyl transferase by taurocholate is not demon-
strable until 2.5 h after the start of the perfusion, i.e.
after removal of 20-30 per,cent of the enzyme from
the membrane, in contrast to 7—14 per cent in the
case of alkaline phosphatase at about l h. Another
example is the striking increase of urinary (tubular)
alanine aminopeptidase in chronic cholestasis (8). It
usually amo nts to 10-15 times the normal mean.
Such excretion rates could not be maintained with-
out a corresponding increase in the rate of synthesis.
This, however, depends on the energy Situation in
the mucosa. In a previous communication (9) results
of the in vivo method were compared with thpse of
in vitro experiments. It is a characteristic feature of
the latter that after an initial steep increase, the re-
lease rates of enzymes decline rapidly. This might be
due to hypoxia and, consequently, defective synthe-
sis, and indeed, evidence was recently provided (10)
that the original Wilson- Wiseman method s used by
us suffers from insufficient oxygenation.
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As for symbols and n see fig. 1.
Significance of differences between taurocholate release without and with previous cycloheximide administration:
* p < 0.05, ** p < 0.01, *** p < 0.001
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